Navigation Links
UCI receives prestigious federal research award to hasten medical advances

Irvine, Calif., July 14, 2010 The Institute for Clinical & Translational Science at UC Irvine will get $20 million over five years from the National Institutes of Health to speed the transformation of scientific discoveries into medical advances for patients.

UCI is the first medical research institution in Orange County and the eighth statewide to receive the competitive Clinical & Translational Science Award. It enters a prestigious national consortium of CTSA beneficiaries whose membership will be capped at 60 by 2012. The NIH announced nine awardees today.

The sixth-largest grant in UCI history, the CTSA will foster multidisciplinary research involving the community in a wide range of fields such as genetics, diabetes, gerontology, pediatrics, cancer and infectious diseases while funding efforts to overcome impediments to biomedical innovation.

"With this award, UCI joins a select group of institutions supported by NIH to forge a new direction for clinical research in the U.S. for a generation to come," said Dr. Dan Cooper, ICTS director and primary CTSA investigator. "The grant will jump-start our endeavors to build effective multidisciplinary research teams to tackle important health issues, and it will bolster efforts to involve our community in the excitement of clinical discovery as partners."

Specifically, he said, the CTSA will support:

  • Development of novel technologies, such as devices that can detect diseases like diabetes in exhaled breath.
  • Innovative pilot studies, such as one for the early identification of cerebral palsy in babies.
  • Successful navigation of regulatory barriers to clinical studies.
  • Research into biostatistics, study design and bioethics.
  • Vigorous efforts to involve community partners in a meaningful way with new research projects particularly relevant to Southern California residents.
  • Creation of outstanding research facilities and the hiring of research nursing and study coordinators for UCI translational scientists.
  • Training of the next generation of clinical scientists through certificate and master's programs in clinical research.

"A critical goal of biomedical research is to transform discoveries into preventions, treatments and cures," said NIH director Dr. Francis S. Collins. "By working together, CTSA institutions are removing barriers to research, training new generations of clinical and laboratory research teams, and providing them with the equipment and resources they need."

Founded in 2006, the ICTS is the lynchpin of UCI's clinical research efforts. Housed at UC Irvine Medical Center, it encompasses hundreds of studies by faculty and staff members.

"Our expectation is that with the CTSA's considerable support, the ICTS will generate new knowledge of immediate and long-term importance to the healthcare of people everywhere," Cooper said. "The ICTS will inspire the next generation of healthcare professionals to focus on the possibilities of medicine and turn these ideas into reality."


Contact: Tom Vasich
University of California - Irvine

Related biology news :

1. Innovotech receives funding to advance environmentally friendly agricultural crop protection product
2. Dr. Jayne Fulkerson receives $3.2 million NIH grant
3. University receives $19 million to monitor carbon storage project
4. UCLAs James Liao receives Presidential Green Chemistry Challenge Award from EPA
5. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
6. Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize
7. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
8. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
9. HJF research psychologist receives Sleep Research Societys Young Investigator Award
10. VIB-UGent scientist Jiri Friml receives Koerber European Science Award 2010
11. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
Post Your Comments:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology: